EDGAR filings
Every filing EDGAR's full-index lists, from every filer: companies, insiders, funds and filing agents. A search that names no form type, ticker or filer CIK covers at most 31 days and defaults to the last 7.
EDGAR holds what was filed electronically. Electronic filing began in 1993 (the earliest filing here is of 1993-02-11) and was phased in filer by filer until May 1996: filings made on paper before 1993, and during the phase-in by a filer not yet on EDGAR, are not on EDGAR and therefore not here.
50 rows on this page.
| Filed | Form | Filer | Category | 8-K items / description | Accession |
|---|---|---|---|---|---|
| 2026-11-18 | 10-K |
ENTA
ENANTA PHARMACEUTICALS INC
CIK 1177648
|
Financial reports | 10-K | 0001193125-26-466170 |
| 2026-11-16 | 8-K |
ENTA
ENANTA PHARMACEUTICALS INC
CIK 1177648
|
Current reports | 2.02 Results of Operations and Financial Condition; 9.01 Financial Statements and Exhibits | 0001193125-26-463508 |
| 2026-11-16 | SCHEDULE 13G |
ENTA
ENANTA PHARMACEUTICALS INC
CIK 1177648
|
Ownership | 0001104659-26-128729 | |
| 2026-11-16 | SCHEDULE 13G/A |
ENTA
ENANTA PHARMACEUTICALS INC
CIK 1177648
|
Ownership | 0000908834-26-000532 | |
| 2026-10-29 | 8-K |
ENTA
ENANTA PHARMACEUTICALS INC
CIK 1177648
|
Current reports | 8.01 Other Events | 0001193125-26-437774 |
| 2026-10-28 | 8-K |
ENTA
ENANTA PHARMACEUTICALS INC
CIK 1177648
|
Current reports | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; 7.01 Regulation FD Disclosure; 9.01 Financial Statements and Exhibits | 0001193125-26-435092 |
| 2026-10-27 | SCHEDULE 13G |
ENTA
ENANTA PHARMACEUTICALS INC
CIK 1177648
|
Ownership | 0002052113-26-001073 | |
| 2026-08-14 | SCHEDULE 13G/A |
ENTA
ENANTA PHARMACEUTICALS INC
CIK 1177648
|
Ownership | 0001172661-26-003479 | |
| 2026-08-14 | SCHEDULE 13G/A |
ENTA
ENANTA PHARMACEUTICALS INC
CIK 1177648
|
Ownership | 0000908834-26-000416 | |
| 2026-08-12 | 10-Q |
ENTA
ENANTA PHARMACEUTICALS INC
CIK 1177648
|
Financial reports | 10-Q | 0001193125-26-345719 |
| 2026-08-10 | 4 |
ENTA
ENANTA PHARMACEUTICALS INC
CIK 1177648
|
Ownership | 0002064832-26-000266 | |
| 2026-08-10 | 8-K |
ENTA
ENANTA PHARMACEUTICALS INC
CIK 1177648
|
Current reports | 2.02 Results of Operations and Financial Condition; 9.01 Financial Statements and Exhibits | 0001193125-26-342336 |
| 2026-07-02 | 8-K |
ENTA
ENANTA PHARMACEUTICALS INC
CIK 1177648
|
Current reports | 1.01 Entry into a Material Definitive Agreement; 9.01 Financial Statements and Exhibits | 0001193125-26-294837 |
| 2026-07-02 | 424B5 |
ENTA
ENANTA PHARMACEUTICALS INC
CIK 1177648
|
Registrations and prospectuses | 0001193125-26-294828 | |
| 2026-06-23 | 8-K |
ENTA
ENANTA PHARMACEUTICALS INC
CIK 1177648
|
Current reports | 8.01 Other Events | 0001193125-26-279803 |
| 2026-06-18 | 8-K |
ENTA
ENANTA PHARMACEUTICALS INC
CIK 1177648
|
Current reports | 7.01 Regulation FD Disclosure; 9.01 Financial Statements and Exhibits | 0001193125-26-274950 |
| 2026-05-13 | S-8 |
ENTA
ENANTA PHARMACEUTICALS INC
CIK 1177648
|
Registrations and prospectuses | 0001193125-26-220600 | |
| 2026-05-13 | 10-Q |
ENTA
ENANTA PHARMACEUTICALS INC
CIK 1177648
|
Financial reports | 10-Q | 0001193125-26-220572 |
| 2026-05-11 | 8-K |
ENTA
ENANTA PHARMACEUTICALS INC
CIK 1177648
|
Current reports | 2.02 Results of Operations and Financial Condition; 9.01 Financial Statements and Exhibits | 0001193125-26-216735 |
| 2026-03-26 | 8-K |
ENTA
ENANTA PHARMACEUTICALS INC
CIK 1177648
|
Current reports | 8.01 Other Events | 0001193125-26-125113 |
| 2026-03-26 | SCHEDULE 13G/A |
ENTA
ENANTA PHARMACEUTICALS INC
CIK 1177648
|
Ownership | 0000102909-26-001192 | |
| 2026-03-13 | 4 |
ENTA
ENANTA PHARMACEUTICALS INC
CIK 1177648
|
Ownership | 0002064832-26-000143 | |
| 2026-03-13 | 4 |
ENTA
ENANTA PHARMACEUTICALS INC
CIK 1177648
|
Ownership | 0002064832-26-000142 | |
| 2026-03-13 | 4 |
ENTA
ENANTA PHARMACEUTICALS INC
CIK 1177648
|
Ownership | 0002064832-26-000141 | |
| 2026-03-13 | 4 |
ENTA
ENANTA PHARMACEUTICALS INC
CIK 1177648
|
Ownership | 0002064832-26-000140 | |
| 2026-03-13 | 4 |
ENTA
ENANTA PHARMACEUTICALS INC
CIK 1177648
|
Ownership | 0002064832-26-000139 | |
| 2026-03-13 | 4 |
ENTA
ENANTA PHARMACEUTICALS INC
CIK 1177648
|
Ownership | 0002064832-26-000138 | |
| 2026-03-12 | 8-K |
ENTA
ENANTA PHARMACEUTICALS INC
CIK 1177648
|
Current reports | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; 5.07 Submission of Matters to a Vote of Security Holders; 9.01 Financial Statements and Exhibits | 0001193125-26-104109 |
| 2026-02-20 | EFFECT |
ENTA
ENANTA PHARMACEUTICALS INC
CIK 1177648
|
Registrations and prospectuses | 9999999995-26-000642 | |
| 2026-02-17 | CORRESP |
ENTA
ENANTA PHARMACEUTICALS INC
CIK 1177648
|
Other | 0001193125-26-055328 | |
| 2026-02-17 | UPLOAD |
ENTA
ENANTA PHARMACEUTICALS INC
CIK 1177648
|
Other | 0000000000-26-001607 | |
| 2026-02-13 | 4 |
ENTA
ENANTA PHARMACEUTICALS INC
CIK 1177648
|
Ownership | 0002064832-26-000016 | |
| 2026-02-13 | 4 |
ENTA
ENANTA PHARMACEUTICALS INC
CIK 1177648
|
Ownership | 0002064832-26-000014 | |
| 2026-02-13 | 4 |
ENTA
ENANTA PHARMACEUTICALS INC
CIK 1177648
|
Ownership | 0002064832-26-000012 | |
| 2026-02-13 | 4 |
ENTA
ENANTA PHARMACEUTICALS INC
CIK 1177648
|
Ownership | 0002064832-26-000010 | |
| 2026-02-13 | 4 |
ENTA
ENANTA PHARMACEUTICALS INC
CIK 1177648
|
Ownership | 0002064832-26-000008 | |
| 2026-02-13 | 4 |
ENTA
ENANTA PHARMACEUTICALS INC
CIK 1177648
|
Ownership | 0002064832-26-000006 | |
| 2026-02-13 | SCHEDULE 13G/A |
ENTA
ENANTA PHARMACEUTICALS INC
CIK 1177648
|
Ownership | 0001172661-26-000711 | |
| 2026-02-11 | S-3 |
ENTA
ENANTA PHARMACEUTICALS INC
CIK 1177648
|
Registrations and prospectuses | 0001193125-26-046712 | |
| 2026-02-11 | 10-Q |
ENTA
ENANTA PHARMACEUTICALS INC
CIK 1177648
|
Financial reports | 10-Q | 0001193125-26-046502 |
| 2026-02-09 | 8-K |
ENTA
ENANTA PHARMACEUTICALS INC
CIK 1177648
|
Current reports | 2.02 Results of Operations and Financial Condition; 9.01 Financial Statements and Exhibits | 0001193125-26-042812 |
| 2026-02-05 | SCHEDULE 13G/A |
ENTA
ENANTA PHARMACEUTICALS INC
CIK 1177648
|
Ownership | 0000908834-26-000042 | |
| 2026-01-26 | ARS |
ENTA
ENANTA PHARMACEUTICALS INC
CIK 1177648
|
Financial reports | 0001193125-26-022589 | |
| 2026-01-26 | DEFA14A |
ENTA
ENANTA PHARMACEUTICALS INC
CIK 1177648
|
Proxies | 0001193125-26-022585 | |
| 2026-01-26 | DEF 14A |
ENTA
ENANTA PHARMACEUTICALS INC
CIK 1177648
|
Proxies | 0001193125-26-022558 | |
| 2026-01-20 | SCHEDULE 13G/A |
ENTA
ENANTA PHARMACEUTICALS INC
CIK 1177648
|
Ownership | 0001104659-26-005096 | |
| 2025-12-05 | 4 |
ENTA
ENANTA PHARMACEUTICALS INC
CIK 1177648
|
Ownership | 0002064832-25-000070 | |
| 2025-12-05 | 4 |
ENTA
ENANTA PHARMACEUTICALS INC
CIK 1177648
|
Ownership | 0002064832-25-000067 | |
| 2025-12-05 | 4 |
ENTA
ENANTA PHARMACEUTICALS INC
CIK 1177648
|
Ownership | 0002064832-25-000065 | |
| 2025-12-05 | 4 |
ENTA
ENANTA PHARMACEUTICALS INC
CIK 1177648
|
Ownership | 0002064832-25-000063 |